Nuveen Asset Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $723K | Hold |
380,535
| – | – | ﹤0.01% | 2840 |
|
|
2024
Q3 | $502K | Hold |
380,535
| – | – | ﹤0.01% | 3018 |
|
|
2024
Q2 | $388K | Buy |
+380,535
| New | +$388K | ﹤0.01% | 3076 |
|
|
2022
Q1 | – | Sell |
-580,106
| Closed | -$1.33M | – | 3296 |
|
|
2021
Q4 | $1.33M | Buy |
580,106
+7,107
| +1% | +$16.3K | ﹤0.01% | 2744 |
|
|
2021
Q3 | $1.66M | Sell |
572,999
-7,011
| -1% | -$20.3K | ﹤0.01% | 2759 |
|
|
2021
Q2 | $2.2M | Buy |
580,010
+63,267
| +12% | +$240K | ﹤0.01% | 2665 |
|
|
2021
Q1 | $1.75M | Sell |
516,743
-300
| -0.1% | -$1.02K | ﹤0.01% | 2680 |
|
|
2020
Q4 | $5.17M | Sell |
517,043
-1,154,823
| -69% | -$11.5M | ﹤0.01% | 2054 |
|
|
2020
Q3 | $16.7M | Buy |
1,671,866
+98,926
| +6% | +$989K | 0.01% | 1180 |
|
|
2020
Q2 | $21.4M | Buy |
1,572,940
+87,084
| +6% | +$1.18M | 0.01% | 1000 |
|
|
2020
Q1 | $11.3M | Sell |
1,485,856
-241,427
| -14% | -$1.83M | 0.01% | 1220 |
|
|
2019
Q4 | $10.9M | Buy |
1,727,283
+13,777
| +0.8% | +$87.1K | ﹤0.01% | 1543 |
|
|
2019
Q3 | $6.72M | Buy |
1,713,506
+84,478
| +5% | +$331K | ﹤0.01% | 1794 |
|
|
2019
Q2 | $7.89M | Buy |
+1,629,028
| New | +$7.89M | ﹤0.01% | 1748 |
|